13-Nov-2024
No headlines found.
R1 RCM Reports Third Quarter 2024 Results
Globe Newswire (Tue, 5-Nov 7:00 AM ET)
Globe Newswire (Mon, 4-Nov 10:27 AM ET)
Kuehn Law Encourages CPTN, ALTR, RCM, and WMPN Investors to Contact Law Firm
Globe Newswire (Mon, 4-Nov 9:03 AM ET)
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
Globe Newswire (Wed, 30-Oct 9:30 AM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CPTN, ESGR, RCM on Behalf of Shareholders
PRNewswire (Wed, 23-Oct 3:32 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, OB, AG, GATO on Behalf of Shareholders
PRNewswire (Thu, 17-Oct 8:38 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, PRMW, RCM on Behalf of Shareholders
Globe Newswire (Tue, 15-Oct 9:25 AM ET)
PRNewswire (Mon, 14-Oct 10:59 AM ET)
Business Wire (Sat, 7-Sep 1:34 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, BALY, RCM on Behalf of Shareholders
PRNewswire (Tue, 20-Aug 10:37 AM ET)
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
R1 Rcm trades on the NASDAQ stock market under the symbol RCM.
As of November 13, 2024, RCM stock price climbed to $14.30 with 1,419,920 million shares trading.
RCM has a beta of -0.16, meaning it tends to be less sensitive to market movements. RCM has a correlation of 0.00 to the broad based SPY ETF.
RCM has a market cap of $6.04 billion. This is considered a Mid Cap stock.
Last quarter R1 Rcm reported $657 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.02.
In the last 3 years, RCM traded as high as $27.86 and as low as $6.71.
The top ETF exchange traded funds that RCM belongs to (by Net Assets): IJH, VTI, VB, VXF, VBK.
RCM has outperformed the market in the last year with a return of +38.6%, while the SPY ETF gained +37.1%. However, in the most recent history, RCM shares have underperformed the stock market with its stock returning +2.5% in the last 3 month period and +0.4% for the last 2 week period, while SPY has returned +12.3% and +2.7%, respectively.
RCM support price is $14.28 and resistance is $14.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RCM shares will trade within this expected range on the day.